ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 361127 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 361127; 2) Community: the network communities that were significantly associated with the response to NSC 361127; 3) Molecule: the relationships between components within communities and NSC 361127; 4) MDR: the compounds that were significantly associated with the NSC 361127.

NSC Compound Enrichment Correlation
NSC 630703 Acridomide 0.0282295482823988 0.089363352
NSC 637037 O-6-Benzylguanine 0.0282295482823988 -0.15646599
NSC 651334 Null 0.0282295482823988 0.11991262
NSC 658228 Null 0.0282295482823988 0.080535671
NSC 664161 Null 0.0282295482823988 0.048431692
NSC 670964 Null 0.0282295482823988 0.24061779
NSC 671139 Null 0.0282295482823988 -0.042144938
NSC 683664 2-Azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaene- 3,20,22-trione, 9-[[(amino)carbonyl]oxy]-8,14-dimethoxy- 4,10,12,16-tetramethyl-13-[3-(dimethylamino)- 1-oxopropoxy)-19-[(2-propenyl)amino]-,stere 0.0282295482823988 0.35307478
NSC 702327 Benzene-1,4-diol, 2-[19-(hydroxymethyl)-3,7,11,15,23,27,31-heptamethyl- 2,6,10,14,18,22,26,30-dotriacontaoctaenyl]-, (2E,6E,10E,14Z,18Z,22E,26E)- 0.0282295482823988 0.30769016
NSC 707149 Card-20(22)-enolide, 16-(acetyloxy)-3-[(6-deoxy-3-O-methyl- .beta.-D-galactopyranosyl)oxy]-14-hydroxy-,(3.beta.,5.beta.,16.beta.)- (9CI) 0.0282295482823988 0.038310424
Total:71  Current:39    [First] [Prev] [Next] [Last]